| # | Article | Year | Clicks |
|---|---|---|---|
| 3 |
Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders.
pp. 107480
|
2020 | 370 |
| 5 |
Cannabinoids in the descending pain modulatory circuit: Role in inflammation.
pp. 107495
|
2020 | 305 |
| 1 |
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
pp. 107464
|
2019 | 304 |
| 4 |
Autoimmune phenotypes in schizophrenia reveal novel treatment targets.
Vol. 189 pp. 184-198
|
2018 | 303 |
| 6 |
Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
pp. 107541
|
2020 | 264 |
| 7 |
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
pp. 107579
|
2020 | 255 |
| 2 |
Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?
pp. 107475
|
2020 | 236 |
| Full Name | pharmacology & therapeutics |
|---|---|
| Short Name | pharmacol ther |
| Abbreviation | pharmacol ther |
| ISSN | 1879-016X |
| Rank | 17.52 / 100 |